ReviewBlood2021

Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies.

Deborah M Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.